• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[诱导多能干细胞在视网膜退行性疾病中的当前研究]

[Current studies on induced pluripotent stem cells in retinal degenerative diseases].

作者信息

Zhu Jia-li, Zheng Qin-xiang, Li Wen-sheng

机构信息

Eye Hospital, Wenzhou Medical College, Wenzhou 325027, China.

出版信息

Zhonghua Yan Ke Za Zhi. 2012 Apr;48(4):374-8.

PMID:22800459
Abstract

Retinal degeneration diseases are a group of severe eye diseases that can lead to blindness. They are characterized by degeneration and apoptosis of photoreceptor cells and still lacking effective therapeutic procedures. Pluripotent stem cells (induced pluripotent stem cells, iPS cells) obtained from somatic cell reprogramming are similar to the embryonic stem cells (embryonic stem cells, ES cells), which have unlimited proliferation, differentiation and memory characteristics. Retinal cells from iPS cells have been used in cell transplantation for the treatment of retinal diseases, for the study of pathogenesis and drug toxicity evaluation in retinal degenerative diseases. This may provide new ideas and novel procedures for the treatment of retinal degenerative diseases in the future.

摘要

视网膜退行性疾病是一组可导致失明的严重眼部疾病。它们的特征是光感受器细胞的退化和凋亡,并且仍然缺乏有效的治疗方法。通过体细胞重编程获得的多能干细胞(诱导多能干细胞,iPS细胞)与胚胎干细胞(胚胎干细胞,ES细胞)相似,具有无限增殖、分化和记忆特性。来自iPS细胞的视网膜细胞已被用于细胞移植治疗视网膜疾病、研究视网膜退行性疾病的发病机制和药物毒性评估。这可能为未来治疗视网膜退行性疾病提供新的思路和方法。

相似文献

1
[Current studies on induced pluripotent stem cells in retinal degenerative diseases].[诱导多能干细胞在视网膜退行性疾病中的当前研究]
Zhonghua Yan Ke Za Zhi. 2012 Apr;48(4):374-8.
2
Induced pluripotent stem cell research: a revolutionary approach to face the challenges in drug screening.诱导多能干细胞研究:应对药物筛选挑战的革命性方法。
Arch Pharm Res. 2012 Feb;35(2):245-60. doi: 10.1007/s12272-012-0205-9. Epub 2012 Feb 28.
3
Docosahexaenoic acid promotes dopaminergic differentiation in induced pluripotent stem cells and inhibits teratoma formation in rats with Parkinson-like pathology.二十二碳六烯酸促进诱导多能干细胞中多巴胺能分化,并抑制帕金森样病理大鼠中的畸胎瘤形成。
Cell Transplant. 2012;21(1):313-32. doi: 10.3727/096368911X580572. Epub 2011 Jun 7.
4
Induced pluripotent stem cells generate both retinal ganglion cells and photoreceptors: therapeutic implications in degenerative changes in glaucoma and age-related macular degeneration.诱导多能干细胞可生成视网膜神经节细胞和光感受器:在青光眼退行性病变和年龄相关性黄斑变性中的治疗意义。
Stem Cells. 2010 Apr;28(4):695-703. doi: 10.1002/stem.320.
5
Therapeutic potential of motor neurons differentiated from embryonic stem cells and induced pluripotent stem cells.胚胎干细胞和诱导多能干细胞分化的运动神经元的治疗潜力。
Arch Med Res. 2012 Jan;43(1):1-10. doi: 10.1016/j.arcmed.2012.01.007. Epub 2012 Jan 30.
6
Toward the generation of rod and cone photoreceptors from mouse, monkey and human embryonic stem cells.从小鼠、猴和人类胚胎干细胞生成视杆和视锥光感受器。
Nat Biotechnol. 2008 Feb;26(2):215-24. doi: 10.1038/nbt1384. Epub 2008 Feb 3.
7
Stem cells for retinal repair.用于视网膜修复的干细胞。
Dev Ophthalmol. 2014;53:70-80. doi: 10.1159/000357328. Epub 2014 Apr 10.
8
Pluripotent human stem cells for the treatment of retinal disease.人多能干细胞治疗视网膜疾病。
J Cell Physiol. 2012 Feb;227(2):457-66. doi: 10.1002/jcp.22814.
9
Potential Role of Induced Pluripotent Stem Cells as Regenerative Medicine in Retinal Cell Damage.诱导多能干细胞作为再生医学在视网膜细胞损伤中的潜在作用。
J Environ Pathol Toxicol Oncol. 2018;37(4):305-316. doi: 10.1615/JEnvironPatholToxicolOncol.2018027447.
10
Induced pluripotent stem cell therapies for retinal disease.用于视网膜疾病的诱导多能干细胞疗法。
Curr Opin Neurol. 2010 Feb;23(1):4-9. doi: 10.1097/WCO.0b013e3283352f96.